Effect of Streptococcus salivarius K12 on the In vitro growth of Candida albicans and its protective effect in an oral candidiasis model

Applied and Environmental Microbiology

Volumn 78, Issue 7, 2012, Pages 2190-2199

  Ishijima, Sanae A ^a   Hayama, Kazumi ^a   Burton, Jeremy P ^b   Reid, Gregor ^d   Okada, Masashi ^a   Matsushita, Yuji ^c   Abe, Shigeru ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Tradepia Co   (Japan)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBICANS; ANTI-MICROBIAL ACTIVITY; BACTERIOCINS; CANDIDA ALBICANS; CULTURE MEDIUM; DENTURE ACRYLIC RESIN; ELDERLY PEOPLE; IN-VITRO; INHIBITORY ACTIVITY; MYCELIAL GROWTH; ORAL CARE; PETRI DISH; PLATE ASSAY; PRECULTURE; PROBIOTICS; PROTECTIVE EFFECTS; QUALITY OF LIFE; THERAPEUTIC ACTIVITY;

ADHESION; BACTERIA; CELL ADHESION; FLUORESCENCE MICROSCOPY; MAMMALS; YEAST;

CANDIDA;

BACTERIOCIN; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOASSAY; CELL ORGANELLE; FLUORESCENCE SPECTROSCOPY; GROWTH RATE; INHIBITION; NUMERICAL MODEL; RESIN; RODENT; YEAST;

ANIMAL; ARTICLE; CANDIDA ALBICANS; CELL ADHESION; CLASSIFICATION; DISEASE MODEL; DRUG EFFECT; FEMALE; FUNGUS HYPHAE; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE; PATHOLOGY; STREPTOCOCCUS; THRUSH; TONGUE; TREATMENT OUTCOME;

ANIMALS; BACTERIOCINS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELL ADHESION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPHAE; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; STREPTOCOCCUS; TONGUE; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS; MUS; STREPTOCOCCUS SALIVARIUS;

EID: 84861114274     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.07055-11     Document Type: Article

References (31)

1. Abe S, Satoh T, Tokuda Y, Tansho S, Yamaguchi H. 1994. A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans. Microbiol. Immunol. 38:385-388.
2. Burton JP, Chilcott CN, Tagg JR. 2005. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis. 11(Suppl 1):29-31.
3. Burton JP, et al. 2011. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebocontrolled, double-blind study. Food Chem. Toxicol. 49:2356-2364.
4. Burton JP, Chilcott C, Wescombe PA, Tagg JR. 2010. Extended safety data for the oral cavity probiotic Streptococcus salivarius K12. Probiot. Antimicrob. Prot. 2:135-144.
5. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. 2006. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl. Environ. Microbiol. 72:3050-3053.
6. Carlsson J. 1971. Nutritional requirements of Streptococcus salivarius. J. Gen. Microbiol. 67:69-76.
7. De Sordi L, Mühlschlegel FA. 2009. Quorum sensing and fungal-bacterial interactions in Candida albicans: a communicative network regulating microbial coexistence and virulence. FEMS Yeast Res. 9:990-999.
8. Elguezabal N, Maza JL, Dorronsoro S, Ponton J. 2008. Whole saliva has a dual role on the adherence of Candida albicans to polymethylmetacrylate. Open Dent. J. 2:1-4.
9. Ellepola AN, Samaranayake LP. 2000. Oral candidal infections and antimycotics. Crit. Rev. Oral Biol. Med. 11:172-198.
10. Hogan DA, Vik A, Kolter R. 2004. A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology. Mol. Microbiol. 54:1212-1223.
11. Hyink O, et al. 2007. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl. Environ. Microbiol. 73:1107-1113.
12. Ishijima SA, et al. 2011. N-Acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis. Med. Mycol [Epub ahead of print.] doi:10.3109/13693786.2011.598194.
13. James SM, Tagg JR. 1991. The prevention of dental caries by BLISmediated inhibition of mutans streptococci. N. Z. Dent. J. 87:80-83.
14. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T. 2003. Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate. J. Infect. Chemother. 9:215-220.
15. Kamagata-Kiyoura Y, Abe S. 2005. Recent studies on oral candidiasis using a murine model. J. Oral Biosci. 47:60-64.
16. Kumamoto CA, Vinces MD. 2005. Contributions of hyphae and hyphaco-regulated genes to Candida albicans virulence. Cell. Microbiol. 7:1546-1554.
17. Morales DK, Hogan DA. 2010. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 6:1-4.
18. Nickerson KW, Atkin AL, Hornby JM. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72:3805-3813.
19. Ogawa A, et al. 2011. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl. Environ. Microbiol. 77:1572-1580.
20. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterialfungal interactions. Nat. Rev. Microbiol. 8:340-349.
21. Pereira-Cenci T, et al. 2008. The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. Arch. Oral Biol. 53:755-764.
22. Sardi JC, et al. 2010. Candida spp. in periodontal disease: a brief review. J. Oral Sci. 52:177-185.
23. Shapiro RS, Robbins N, Cowen LE. 2011. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75:213-267.
24. Shirtliff ME, Peters BM, Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299:1-8.
25. Tagg JR, Bannister LV. 1979. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J. Med. Microbiol. 12:397-411.
26. Tagg JR, Dajani AS, Wannamaker LW. 1976. Bacteriocins of grampositive bacteria. Bacteriol. Rev. 40:722-756.
27. Takakura N, et al. 2003. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol. Immunol. 47: 321-326.
28. Tamura S, et al. 2009. Inhibiting effects of Streptococcus salivarius on competence-stimulating peptide-dependent biofilm formation by Streptococcus mutans. Oral Microbiol. Immunol. 24:152-161.
29. Thompson GR, III, et al. 2010. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109:488-495.
30. Walls T, Power DA, Tagg JR. 2003. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J. Med. Microbiol. 52:829-833.
31. Wescomebe PA, Heng NCK, Burton JP, Chilcott CN, Tagg R. 2009. Streptococcus bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 4:819-835.